Back to 
HRT Financial LP
HRT Financial LP
SXTC
2 quarters
Position history for HRT Financial LP's holdings in China SXT Pharmaceuticals, Inc.
No. HRT Financial exited its SXTC (China SXT Pharmaceuticals) position in Q4 2025. Its Q3 2025 13F listed 26,749 shares worth $42,000. HRT Financial first reported SXTC in Q3 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$42,000
Total Shares Change
-26,749
Quarter-by-Quarter History
Other major holders of SXTC: Citadel Advisors LLC, Invesco Ltd., UBS Group AG, Geode Capital Management, LLC